FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1650573014> ?p ?o ?g. }

• W1650573014 endingPage "3973" @default.
• W1650573014 startingPage "3973" @default.
• W1650573014 abstract "This study aimed to formulate an optimized acyclovir (ACV) nanoemulsion hydrogel in order to provide a solution for the slow, variable, and incomplete oral drug absorption in patient suffering from herpes simplex viral infection. Solubility of ACV in different oils, surfactants, and cosurfactants was explored utilizing a cubic model mixture design to obtain a nanoemulsion with minimum globule size. Preparation of an optimized ACV nanoemulsion hydrogel using a three-factor, three-level Box-Behnken statistical design was conducted. The molecular weight of chitosan (X1), percentage of chitosan (X2), and percentage of Eugenol as a skin permeation enhancer (X3) were selected to study their effects on hydrogel spreadability (Y1) and percent ACV permeated through rat skin after 2.5 hours (Y2). A pharmacokinetic study of the optimized ACV nanoemulsion hydrogel was conducted in rats. Mixtures of clove oil and castor oil (3:1 ratio), Tween 80 and Span 80 (3:1 ratio), and propylene glycol and Myo-6V (3:1 ratio) were selected as the oil, surfactant, and cosurfactant phases, respectively. Statistical analysis indicated that the molecular weight of chitosan has a significant antagonistic effect on spreadability, but has no significant effect on the percent ACV permeated. The percentage of chitosan also has a significant antagonistic effect on the spreadability and percent ACV permeated. On the other hand, the percentage of Eugenol has a significant synergistic effect on percent ACV permeated, with no effect on spreadability. The ex vivo study demonstrated that the optimized ACV nanoemulsion hydrogel showed a twofold and 1.5-fold higher permeation percentage than the control gel and marketed cream, respectively. The relative bioavailability of the optimized ACV nanoemulsion hydrogel improved to 535.2% and 244.6% with respect to the raw ACV hydrogel and marketed cream, respectively, confirming improvement of the relative bioavailability of ACV in the formulated nanoemulsion hydrogel." @default.
• W1650573014 created "2016-06-24" @default.
• W1650573014 creator A5010490417 @default.
• W1650573014 creator A5012905296 @default.
• W1650573014 creator A5030404252 @default.
• W1650573014 creator A5055769461 @default.
• W1650573014 creator A5063060227 @default.
• W1650573014 date "2015-06-01" @default.
• W1650573014 modified "2023-10-12" @default.
• W1650573014 title "Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections" @default.
• W1650573014 cites W1497392903 @default.
• W1650573014 cites W1970603142 @default.
• W1650573014 cites W2021742090 @default.
• W1650573014 cites W2037102252 @default.
• W1650573014 cites W2039748268 @default.
• W1650573014 cites W2044197270 @default.
• W1650573014 cites W2047158607 @default.
• W1650573014 cites W2066296333 @default.
• W1650573014 cites W2083153400 @default.
• W1650573014 cites W2086722911 @default.
• W1650573014 cites W2099774314 @default.
• W1650573014 cites W2100520064 @default.
• W1650573014 cites W2114213795 @default.
• W1650573014 cites W2122461523 @default.
• W1650573014 cites W2138551472 @default.
• W1650573014 cites W2150471474 @default.
• W1650573014 cites W2163541003 @default.
• W1650573014 cites W2323396504 @default.
• W1650573014 cites W2468073207 @default.
• W1650573014 cites W4240821889 @default.
• W1650573014 doi "https://doi.org/10.2147/ijn.s83962" @default.
• W1650573014 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4474391" @default.
• W1650573014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26109856" @default.
• W1650573014 hasPublicationYear "2015" @default.
• W1650573014 type Work @default.
• W1650573014 sameAs 1650573014 @default.
• W1650573014 citedByCount "20" @default.
• W1650573014 countsByYear W16505730142016 @default.
• W1650573014 countsByYear W16505730142018 @default.
• W1650573014 countsByYear W16505730142019 @default.
• W1650573014 countsByYear W16505730142020 @default.
• W1650573014 countsByYear W16505730142021 @default.
• W1650573014 countsByYear W16505730142022 @default.
• W1650573014 countsByYear W16505730142023 @default.
• W1650573014 crossrefType "journal-article" @default.
• W1650573014 hasAuthorship W1650573014A5010490417 @default.
• W1650573014 hasAuthorship W1650573014A5012905296 @default.
• W1650573014 hasAuthorship W1650573014A5030404252 @default.
• W1650573014 hasAuthorship W1650573014A5055769461 @default.
• W1650573014 hasAuthorship W1650573014A5063060227 @default.
• W1650573014 hasBestOaLocation W16505730141 @default.
• W1650573014 hasConcept C125287762 @default.
• W1650573014 hasConcept C150077022 @default.
• W1650573014 hasConcept C155574463 @default.
• W1650573014 hasConcept C159047783 @default.
• W1650573014 hasConcept C159985019 @default.
• W1650573014 hasConcept C170295934 @default.
• W1650573014 hasConcept C178790620 @default.
• W1650573014 hasConcept C185592680 @default.
• W1650573014 hasConcept C192562407 @default.
• W1650573014 hasConcept C205679159 @default.
• W1650573014 hasConcept C2522874641 @default.
• W1650573014 hasConcept C2776005048 @default.
• W1650573014 hasConcept C2778229996 @default.
• W1650573014 hasConcept C2779732960 @default.
• W1650573014 hasConcept C2781131970 @default.
• W1650573014 hasConcept C2781196997 @default.
• W1650573014 hasConcept C31903555 @default.
• W1650573014 hasConcept C41625074 @default.
• W1650573014 hasConcept C43617362 @default.
• W1650573014 hasConcept C50670333 @default.
• W1650573014 hasConcept C55493867 @default.
• W1650573014 hasConcept C58226133 @default.
• W1650573014 hasConcept C71924100 @default.
• W1650573014 hasConcept C98274493 @default.
• W1650573014 hasConceptScore W1650573014C125287762 @default.
• W1650573014 hasConceptScore W1650573014C150077022 @default.
• W1650573014 hasConceptScore W1650573014C155574463 @default.
• W1650573014 hasConceptScore W1650573014C159047783 @default.
• W1650573014 hasConceptScore W1650573014C159985019 @default.
• W1650573014 hasConceptScore W1650573014C170295934 @default.
• W1650573014 hasConceptScore W1650573014C178790620 @default.
• W1650573014 hasConceptScore W1650573014C185592680 @default.
• W1650573014 hasConceptScore W1650573014C192562407 @default.
• W1650573014 hasConceptScore W1650573014C205679159 @default.
• W1650573014 hasConceptScore W1650573014C2522874641 @default.
• W1650573014 hasConceptScore W1650573014C2776005048 @default.
• W1650573014 hasConceptScore W1650573014C2778229996 @default.
• W1650573014 hasConceptScore W1650573014C2779732960 @default.
• W1650573014 hasConceptScore W1650573014C2781131970 @default.
• W1650573014 hasConceptScore W1650573014C2781196997 @default.
• W1650573014 hasConceptScore W1650573014C31903555 @default.
• W1650573014 hasConceptScore W1650573014C41625074 @default.
• W1650573014 hasConceptScore W1650573014C43617362 @default.
• W1650573014 hasConceptScore W1650573014C50670333 @default.
• W1650573014 hasConceptScore W1650573014C55493867 @default.
• W1650573014 hasConceptScore W1650573014C58226133 @default.
• W1650573014 hasConceptScore W1650573014C71924100 @default.

• next